[Prevalence of hepatitis B and risk factors as motivation for vaccination campaign among adolescents]

Aten Primaria. 1995 Dec;16(10):602-6.
[Article in Spanish]

Abstract

Objectives: To study the prevalence of viral Hepatitis B infection (VHB) among eighth-year EGB (basic) students; associated risk factors; and the prevalence of Hepatitis C (HC).

Design: A descriptive crossover study.

Setting: Eighth-year EGB students from 8 schools in Villaverde-Usera (Madrid).

Participants: A sample of 262 individuals was used to calculate the prevalence of VHB infection (prevalence defined at 1.5%, precision = 0.015, confidence at 95% and 5% loss).

Measurements and main results: Variables were age, gender, alcohol, tattoos, drugs, family history of drugs, Hepatitis, exchanging syringes, razors, syringes, sexual relations, history of transfusions or surgery. These were obtained from a questionnaire filled in by the students themselves. The definitions were: chronic HB carrier: AgHBS+ in the blood; VHB infection: anti-HBc and/or anti-HBs positives; VHC infection: presence of anti-HC. 402 children answered the questionnaire. Serology was tested in 263 before the vaccination. Average age was 13.3 +/- 0.69. There were 52.8% males and 47.2% females. Prevalence of VHB infection was 2.28% (CI = 0.93-5.14), 6 cases. Prevalence of carriers was 0.38% (CI = 0.02-2.43; one case). There were no VHC positives. No links between VHB and risk practices could be demonstrated.

Conclusions: 1) Low prevalence of VHB infection 2) The zero prevalence of VHC infection is lower than that in healthy donors.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Age Factors
  • Carrier State / epidemiology*
  • Child
  • Cross-Over Studies
  • Cross-Sectional Studies
  • Female
  • Hepatitis B / diagnosis
  • Hepatitis B / epidemiology*
  • Hepatitis B / prevention & control
  • Hepatitis B Antibodies / analysis
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis C / epidemiology
  • Humans
  • Male
  • Risk Factors
  • Sex Factors
  • Spain / epidemiology
  • Vaccination*

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens